메뉴 건너뛰기




Volumn 191, Issue 1, 2004, Pages 194-197

The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence

Author keywords

Duloxetine; Placebo response; Stress urinary incontinence

Indexed keywords

DULOXETINE; PLACEBO;

EID: 4043158564     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.03.089     Document Type: Article
Times cited : (33)

References (12)
  • 1
    • 0036074281 scopus 로고    scopus 로고
    • Duloxetine versus placebo in the treatment of stress urinary incontinence
    • Norton P.A., Zinner N.R., Yalcin I., Bump R.C. Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol. 187:2002;40-48
    • (2002) Am J Obstet Gynecol , vol.187 , pp. 40-48
    • Norton, P.A.1    Zinner, N.R.2    Yalcin, I.3    Bump, R.C.4
  • 2
    • 0041691081 scopus 로고    scopus 로고
    • Duloxetine vs placebo in the treatment of North American women with stress urinary incontinence
    • Dmochowski R.R., Miklos J.R., Norton P.A., Zinner N.R., Yalcin I., Bump R.C., for the Duloxetine UI Study Group. Duloxetine vs placebo in the treatment of North American women with stress urinary incontinence. J Urol. 170:2003;1259-1263
    • (2003) J Urol , vol.170 , pp. 1259-1263
    • Dmochowski, R.R.1    Miklos, J.R.2    Norton, P.A.3    Zinner, N.R.4    Yalcin, I.5    Bump, R.C.6
  • 3
    • 1542374616 scopus 로고    scopus 로고
    • Duloxetine vs placebo in the treatment of European and Canadian women with stress urinary incontinence
    • Van Kerrebroeck P., Abrams P., Lange R., Slack M., Wyndaele J.-J., for the Duloxetine UI Study Group. Duloxetine vs placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG. 111:2004;243-257
    • (2004) BJOG , vol.111 , pp. 243-257
    • Van Kerrebroeck, P.1    Abrams, P.2    Lange, R.3    Slack, M.4    Wyndaele, J.-J.5
  • 4
    • 1342310038 scopus 로고    scopus 로고
    • Duloxetine versus placebo in the treatment of stress urinary incontinence: A four continent randomized clinical trial
    • Millard R.J., Moore K., Rencken R., Yalcin I., Bump R.C., for the Duloxetine UI Study Group. Duloxetine versus placebo in the treatment of stress urinary incontinence: a four continent randomized clinical trial. Br J Urol Int. 93:2004;311-318
    • (2004) Br J Urol Int , vol.93 , pp. 311-318
    • Millard, R.J.1    Moore, K.2    Rencken, R.3    Yalcin, I.4    Bump, R.C.5
  • 5
    • 3242755480 scopus 로고    scopus 로고
    • Drug impact on the SUI component of mixed incontinence: Is it all placebo effect?
    • San Francisco
    • DuBeau CE, V Khullar. Drug impact on the SUI component of mixed incontinence: is it all placebo effect? American Urogynecologic Society Meeting, San Francisco, 2002.
    • (2002) American Urogynecologic Society Meeting
    • DuBeau, C.E.1    Khullar, V.2
  • 6
    • 0004092561 scopus 로고    scopus 로고
    • A randomised, double-blind, placebo controlled trial of pelvic floor exercises in the treatment of genuine stress incontinence
    • Ramsay IN, Thou M. A randomised, double-blind, placebo controlled trial of pelvic floor exercises in the treatment of genuine stress incontinence. Neurourol Urodyn 9:398-9.
    • Neurourol Urodyn , vol.9 , pp. 398-399
    • Ramsay, I.N.1    Thou, M.2
  • 7
    • 0034687072 scopus 로고    scopus 로고
    • Placebo-controlled trials and active-control trials in the evaluation of new treatments - Part 1: Ethical and scientific issues
    • Temple R., Ellenberg S.S. Placebo-controlled trials and active-control trials in the evaluation of new treatments - part 1: ethical and scientific issues. Ann Intern Med. 133:2000;455-463
    • (2000) Ann Intern Med , vol.133 , pp. 455-463
    • Temple, R.1    Ellenberg, S.S.2
  • 8
    • 0034687076 scopus 로고    scopus 로고
    • Placebo-controlled trials and active-control trials in the evaluation of new treatments - Part 2: Practical issues and specific cases
    • Temple R., Ellenberg S.S. Placebo-controlled trials and active-control trials in the evaluation of new treatments - part 2: practical issues and specific cases. Ann Intern Med. 133:2000;474-475
    • (2000) Ann Intern Med , vol.133 , pp. 474-475
    • Temple, R.1    Ellenberg, S.S.2
  • 9
    • 0342902205 scopus 로고    scopus 로고
    • Is the placebo powerless: An analysis of clinical trials comparing placebo with no treatment
    • Hróbjartsson A., Gøtzsche P.C. Is the placebo powerless: an analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 344:2001;1594-1602
    • (2001) N Engl J Med , vol.344 , pp. 1594-1602
    • Hróbjartsson, A.1    Gøtzsche, P.C.2
  • 10
    • 0035942723 scopus 로고    scopus 로고
    • The powerful placebo and the wizard of Oz
    • Bailar J.C. III. The powerful placebo and the wizard of Oz. N Engl J Med. 344:2001;1630-1632
    • (2001) N Engl J Med , vol.344 , pp. 1630-1632
    • Bailar III, J.C.1
  • 11
    • 0000599793 scopus 로고    scopus 로고
    • Pharmacological treatment of urinary incontinence
    • P. Abrams, L. Cardozo, S. Khoury, & A. Wein. Plymouth (UK): Plymbridge Distributors, Inc
    • Andersson K.-E., Appell R., Awad S., Chapple C., Drutz H., Finkbeiner A., et al. Pharmacological treatment of urinary incontinence. Abrams P., Cardozo L., Khoury S., Wein A. Incontinence. 2002;481-511 Plymbridge Distributors, Inc, Plymouth (UK)
    • (2002) Incontinence , pp. 481-511
    • Andersson, K.-E.1    Appell, R.2    Awad, S.3    Chapple, C.4    Drutz, H.5    Finkbeiner, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.